Click to search for your profile
Click to search for condition or expert
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Acute Myeloblastic Leukemia with Maturation
Symptoms, Doctors, Treatments, Advances & More
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Acute Myeloblastic Leukemia with Maturation
What are the alternative names for Acute Myeloblastic Leukemia with Maturation?
Acute myeloblastic leukemia type 2
Acute myeloblastic leukemia M2
AML M2
LAM M2
Top Global Doctors
For Acute Myeloblastic Leukemia with Maturation
Click to see doctor options
CD
Elite
Courtney D. Dinardo
Hematology
Oncology
Internal Medicine
Houston, TX
Click to see doctor options
RS
Elite
Richard M. Stone
Hematology
Oncology
Internal Medicine
Boston, MA
Click to see doctor options
TK
Elite
Tapan M. Kadia
Internal Medicine
Houston, TX
Click to see doctor options
GB
Elite
Gautam M. Borthakur
Hematology
Oncology
Internal Medicine
Houston, TX
Click to see doctor options
EE
Elite
Elihu H. Estey
Oncology
Hematology
Internal Medicine
Seattle, WA
Click to see doctor options
EW
Elite
Eunice S. Wang
Hematology
Internal Medicine
Buffalo, NY
Latest Advances
On Acute Myeloblastic Leukemia with Maturation
Latest Advance
Study
Condition:
Acute Monocytic Leukemia
Journal:
Zhongguo shi yan xue ye xue za zhi
Treatment Used:
Allogeneic Hematopoietic Stem Cell Transplantation
Number of Patients:
71
Published —
December 07, 2020
The study researched the outcomes of allogeneic hematopoietic stem cell transplantation for treating acute monocytic leukemia.
Latest Advance
Study
Condition:
Acute Myeloid Leukemia
Journal:
Medicine
Treatment Used:
Venetoclax and Hypomethylating Agents
Number of Patients:
2
Published —
November 21, 2020
This study evaluated the use of a new combined therapy, venetoclax and hypomethylating agents (HMAs), in two patients with relapsed/refractory acute myeloid leukemia (R/RAML).
Clinical Trials
For Acute Myeloblastic Leukemia with Maturation
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Other, Drug, Radiation, Procedure, Biological
Participants:
240
Start Date:
June 1, 2021
A Randomized Phase II Study to Compare ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
20
Start Date:
February 2021
Lower Doses of CPX-351 as a Novel Approach for the Treatment of Older Patients With Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes